SCOPE 2023: Concerns for Clinical Operations Professionals in 2023

Strategies for ensuring that innovation with PROs remains parallel with advancements in disease detection and progression.

Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.

Anticipating divestment, reallocation of investments, and retrenchment.

Why investing in truly effective training from the outset can pay off exponentially for clinical teams—and serve as a strategic advantage.

With an increased need for operational efficiency, while also leveraging new technologies such as AI, the landscape of clinical operations is evolving, as our February issue explores.